Evolent Health A Aktie
8,70
EUR
+0,15
EUR
+1,75
%
9,63
USD
+0,19
USD
+1,96
%
Werbung
Evolent Health A Aktie Analyse
01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
13.07.16 | Evolent Health A Outperform | FBR Capital | |
29.03.16 | Evolent Health A Outperform | FBR Capital | |
06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung